Wearable artificial kidney (WAK) has been considered an alternative to standard hemodialysis (HD) for many years. Although various novel WAK systems have been recently developed for use in clinical applications, the target performance or standard dose of dialysis has not yet been determined. To calculate the appropriate clearance for a HD-based WAK system for the treatment of patients with end-stage renal disease with various dialysis conditions, a classic variable-volume two-compartment kinetic model was used to simulate an anuric patient with variable target time-averaged creatinine concentration (TAC), daily water intake volume, daily dialysis pause time, and patient body weight. A 70-kg anuric patient with a HD-based WAK system operating for 24 h required dialysis clearances of creatinine of at least 100, 50, and 25 mL/min to achieve TACs of 1.0, 2.0, and 4.0 mg/dL, respectively. The daily water intake volume did not affect the clearance required for dialysis under various conditions. As the pause time per day for the dialysis increased, higher dialysis clearances were required to maintain the target TAC. The present study provided theoretical dialysis doses for an HD-based WAK system to achieve various target TACs through relevant mathematical kinetic modeling. The theoretical results may contribute to the determination of the technical specifications required for the development of a WAK system.
INTRODUCTION
Over the last 60 years, conventional hemodialysis (HD) has been used in end-stage renal disease (ESRD), but the quality of life in patients undergoing HD is still poor, and the mortality rate is quite high. 1, 2 Continuous or frequent dialysis including daily HD, nocturnal HD, or sustained low-efficiency dialysis are believed to be more physiologically compatible than conventional HD because they provide stable control of the acid base, electrolyte and water balances, and blood pressure. [3] [4] [5] [6] Indeed, sleep apnea improvements and cardiovascular risk reductions have been experienced by patients with ESRD who switched from conventional HD to daily nocturnal HD. [7] [8] [9] The recent focus on the development of a wearable artificial kidney (WAK) may be considered to be a progression toward continuous or more frequent dialysis. [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] In the 1970s, an early concept for a WAK consisted merely of a portable dialysis system that allowed the patient to travel or to receive dialysis at home, 21, 22 but the concept could not be widely adopted for clinical use due to the size and weight of the dialysate regeneration circuit. However, recent technical advances in dialysis research have produced a HD system for clinical use that has been effectively miniaturized. Davenport et al. 23 reported that a wearable HD device for a patient with ESRD provided safe and efficient clearance of urea and creatinine. In eight patients with ESRD with a mean dry body weight of 70.5 kg, this wearable device exhibited a mean plasma urea clearance of 22.7 mL/min and a dialysis clearance of creatinine of 20.7 mL/min with a mean blood flow of 58.6 mL and a mean dialysate flow of 47.1 mL. Polaschegg recently proposed that the target performance of an HD-based WAK should be a creatinine clearance (CrCl) of 30 mL/min. 17, 24 However, a number of conditions associated with the application of a WAK were not considered in the determination of this target performance.
The aim of this study was to provide a theoretical method for the calculation of the appropriate clearance for a WAK that can be applied in clinical practice. The patient with ESRD was mathematically simulated using a classic kinetic model and various condition parameters that are relevant to an HD-based WAK, including the uremic toxin concentration, daily water intake volume, daily dialysis pause time, and the patient's body weight. The theoretically required dialysis clearances to achieve various target concentrations under a variety of clinical conditions were calculated.
METHODS

Two-compartment kinetic model and assumptions
Both diffusive and convective kinetics were used in a classic, variable-volume, two-compartment kinetic model to predict the HD dose ( Figure 1) . 25, 26 An anuric patient was modeled, and the total body water was assumed to be half of the patient's dry body weight. The volume distribution of creatinine in the intracellular fluid as the nonperfused compartment and the volume distribution of the extracellular fluid as the perfused compartment were assumed to exist at a ratio of 2:1. The removal rate (Jv, mg/min) and intake rate (Iw, mL/min) for water and the generation rate (G, mg/min) and removal rate (Js, mg/min) for creatinine only occurred in the perfused compartment. The rate of the endogenous creatinine generation was assumed to be 1.0 mg/min for a 70-kg patient, 27 and it was also proportional to the total body weight. The solute transfer rate for creatinine between compartments was expressed as the intercompartment clearance (Kic, mL/min), and this value was assumed to be 275 mL/min. The ultrafiltration rate (Quf, mL/min) was set to maintain the dry body weight in response to the water intake. The initial concentrations of creatinine for both compartments were assumed to be 20 mg/dL, and the dry body weight of the patient was assumed to be between 40 and 100 kg at increments of 10 kg. The daily water intake volume (Vw) was assumed to be equivalent to a range of 0.5-2.0 L/day, and the patient was assumed to consume a third of the daily water intake volume over a period of 30 min, three times per day. For example, if the daily water intake volume was 1.5 L/day, the patient drank 0.5 L of water over 30 min (equivalent to 16.67 mL/min), three times per day. A daily dialysis pause time was considered either if the WAK system requires maintenance for regular cleaning or to replace the blood circuit and dialyzer, or if the patient requires a pause time to take a shower and to have undisturbed sleep. The daily dialysis pause time varied within the range from 0 to 12 h/day. 
where Cp and Cnp are the concentrations of the nonperfused and perfused compartments, respectively; Vp and Vnp are the volumes of the nonperfused and perfused compartment, respectively; G is the generation rate; Kic is the intercompartment clearance; Js is the molecule removal rate; and Jv is the volume removal rate. During the WAK treatment,
where Kd is the dialysis clearance, Kr is the residual renal clearance, Quf is the ultrafiltration rate, and Iw is the water intake rate. Kd was assumed not to decline during a dialysis session. In an anuric patient model, Kr is assumed to be equal to 0, and the third term in the parentheses denotes the convective solute transfer effect when using a high-flux membrane. 28 During the dialysis pause time,
where Kr is also assumed to be equal to 0 and Iw is V w 3 30 × when the patient is drinking water or 0 when not drinking water.
Numerical method and analysis
All of the calculations were performed using MATLAB® software (MathWorks, Inc., Natick, MA, USA). The fourth-and fifth-order Runge-Kutta method was used to solve the governing mass balance equations. The ODE45 function, which used the Runge-Kutta method to solve the differential equation, was applied via a MATLAB script. The results of the calculation provided the creatinine concentration and volume profiles with time steps of 1 min for both compartments over a period of 2 weeks with WAK. The water volume profiles were used to verify that suitable ultrafiltration had been achieved during dialysis.
The time-averaged concentration (TAC) of creatinine during the second week was calculated using the following equation 29 :
where Cp(t) is the concentration profile of creatinine in the perfused compartment, and t is the time (h).
In this study, we sought to determine the dialysis clearance (Kd) that was required for the WAK device to minimize the difference between the achieved TAC and the target TAC ( TAC ) in the second week while the creatinine TAC target varied within the range of 0.5-20.0 mg/dL. arg min
Here, the FMINSEARCH function was employed using the Nelder-Mead simplex algorithm that is integrated in MATLAB to solve the above minimization problem. The relationship of required dialysis clearance with the various independent parameters including TAC, body weight, water intake, and dialysis pause time was observed.
RESULTS
Effect of TAC achievement
When the daily water intake volume and the dialysis pause time remained constant, the required dialysis clearance for creatinine decreased as the TAC target increased (Figure 2) . In other words, a high dialysis clearance was required to achieve a low TAC. As the body weight of the patient increased, the required dialysis clearance for creatinine increased proportionally. In a 70-kg anuric patient, the dialysis clearances of creatinine had to be at least 100, 50, and 25 mL/min to achieve TAC of 1.0, 2.0, and 4.0 mg/dL, respectively. creatinine when a TAC of 1 mg/dL was achieved without a dialysis pause time. The results indicated that the dialysis clearance remained nearly constant as the daily water intake volume varied, which indicates that the water intake volume minimally affected the required dialysis clearance of creatinine. Similarly, the required dialysis clearance of creatinine was not affected by the daily water intake volume regardless of the various TAC targets and daily pause time conditions (data not shown).
Effect of daily water intake volume
Effect of daily dialysis pause time
If the TAC target and the daily water intake volume remained fixed at certain values, the required dialysis clearance gradually increased as the daily dialysis pause time increased (Figure 4) . If the WAK dialysis was halted for 8 h/day in a 70-kg anuric patient, the dialysis clearance for creatinine had to be maintained at a minimum of 35 mL/min to achieve a TAC of 4.0 mg/dL. As the dialysis pause time decreased, lower dialysis clearance of creatinine was required to achieve the same level of TAC. In a manner similar to that described earlier, the achievement of the same TAC target for a fixed daily water intake volume of 1 L/day in a 70-kg anuric patient required the dialysis clearance of creatinine to increase as the daily dialysis pause time increased ( Figure 5) . If the TAC level was required to remain low, the dialysis clear- Figure 6a shows the 2-week time profiles of the creatinine concentration under various patient-related and systemrelated conditions, and Figure 6b shows the representative all-day concentration profiles for both the perfused and nonperfused compartments. Three fluctuations occurred in the perfused compartment during the day as a result of water-drinking events. A mismatch was also observed between the concentrations of the two compartments immediately after finalizing the WAK treatment session, which led to a slight post-dialysis rebound.
Creatinine concentration profiles under various conditions
DISCUSSION
The dialysis clearances required for the WAK system to maintain a specific level of serum creatinine were calculated using a mathematical model for an anuric patient with classical two-compartment kinetics. The results were obtained assuming ideal conditions for the WAK. In practice, variations in the operating conditions and complications related to both the patient and the device should be seriously considered. At this time, we do not have sufficient knowledge to determine the suitable creatinine TAC target levels that should be achieved with the WAK treatment or even for patients who are receiving conventional HD treatment. Kt/V is a measure that has been extensively used to assess the adequacy of a dialysis dose. However, this parameter is inappropriate for treatments with frequencies other than three times per week. Instead, various adequacy assessments have been proposed. The equivalent renal clearance (EKR) was proposed to assess the 
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doses for dialysis modalities that are administered with different frequencies and durations. 29 The EKR can be calculated as the rate of endogenous waste generation (G) divided by the TAC. A normalized value, i.e., the EKRc, can be provided for a typical man with a distribution volume of 40 L to indicate whether the averaged solute concentration is being controlled. The CrCl is widely used to assess both residual renal function and the dose for peritoneal dialysis, which is a type of continuous renal replacement treatment that is similar to WAK. The CrCl can be calculated using various equations that have been introduced in a number of studies.
The typical reference ranges for serum creatinine are 0.5-1.0 mg/dL for healthy females and 0.7-1.2 mg/dL for healthy males. If we expect the WAK system to treat an anuric patient, the dialysis clearances of creatinine are required to be in excess of 56.9, 99.7, and 142.5 mL/min to achieve TAC targets of 1.0 mg/dL, when the patient's body weight is 40, 70, and 100 kg, respectively (Figure 2) . In an anuric patient weighing 70 kg, the Cockcroft-Gault equation can be used to determine that a TAC target creatinine of 1.0 mg/dL is comparable with an EKRc of creatinine of 114 mL/min and a CrCl of 97.2 mL/min for a 40-year-old man. 30, 31 Our results indicate that the two important determinants for the achievement of adequate WAK treatment are the TAC target and the daily dialysis pause time. In conventional intermittent HD, hemodiafiltration, and hemofiltration treatments, large daily water intake volumes result in greater clearance of small molecules. 25 This improvement in efficacy is a result of the dilution of the waste solutes in the body water due to increase in fluid intake and the achievement of a large ultrafiltration volume to maintain the dry body weight. 27 However, during WAK treatment, the daily water intake volume exhibits less influence due to the continuous, long-term slow ultrafiltration through which the water steadily filters out at a constant ultrafiltration rate even when the concentrations of the solutes are instantaneously diluted immediately after the intake of water. However, the intermittent renal replacement treatment holds the water that dilutes the solutes in each compartment until the next dialysis session starts.
For a heavy patient who requires a long daily dialysis pause time, a high dialysis clearance is required to achieve a low TAC target and to achieve a clearance level similar to that of a dialyzer for conventional HD performed three times per week. TACs greater than 4.0 and 5.0 mg/dL can be achieved for patients weighing less than 80 and 100 kg, respectively, who are treated with a WAK system with a dialysis clearance of creatinine of 30 mL/min as previously proposed by Polaschegg for an HD-based WAK. 24 For an anuric patient receiving WAK treatment, a TAC for creatinine below 1.0 mg/dL requires a dialysis clearance of creatinine for the dialyzer of greater than 100 mL/min. Considering a previous clinical experiment 17 and a perceptive proposal, 24 dialysis clearances of creatinine of 20 and 30 mL/min can achieve creatinine TACs of approximately 5.0 and 3.3 mg/dL, respectively, for the same patient model employed for our results (Figure 2) . In other words, it is practically required to maintain an extracorporeal blood flow rate above at least 40-50 mL/min to achieve dialysis clearances of creatinine of 30 mL/min with HD. Regarding the technical aspects, the improvement of molecule clearance requires the employment of a dialyzer with a larger membrane surface area to achieve higher blood and dialysate flow rates without reducing dialysate quality. Because frequent replacements of the dialyzer and blood circuit lead to the increases in dialysis pause times, an efficient and biocompatible dialyzer without clearance deterioration that delays membrane fouling for as long as possible should be used. A userfriendly design should consider the rapid and safe replacement of the disposable parts. Moreover, an automatic cleansing function and risk management algorithm should be integrated into the WAK system. The WAK system developed by Gura et al. 14 replaced the conventional peristaltic roller pump that generates gentle blood flow with a unique double pulsatile flow pump that enhances internal filtration in the dialyzer. The enhanced internal filtration may lead to increased convective molecular transport. Although the convection term is considered in Equation 5 , the enhanced internal filtration by the unique pulsatile flow is not included in the kinetic model. To consider the convective effect of the enhanced internal filtration, the coefficient of the convection term in Equation 5 should be adjusted based on experimental measurements. Because convection is known to be the most efficient in the removal of middle-sized molecules, and diffusive transport known to be primarily dependent on the flow rates of blood and the dialysate, clearance improvements via the enhancement of internal filtration could be more significant for middle-sized molecules such as beta-2 microglobulin compared with small molecules such as urea and creatinine under the same flow rates.
Short stature is a well-known complication for children with malfunctioning kidneys. However, adequate dialysis doses with sufficient nutrition can improve the growth problem. 32 Polaschegg proposed a dialysis clearance of creatinine of 30 mL/min as the target dose for a WAK system to be used as a continuous dialysis modality. 24 If it is possible to obtain a sufficient blood flow rate above 40-50 mL/min via safe vascular access, a WAK system could facilitate HD even in small children whose blood volumes are insufficient to begin with conventional HD machines.
The limitations of this theoretical study should be noted. Fluids, electrolytes, acid base balances, nutrition status, residual renal function, and the removal of middlesized molecules are important parameters for the prognosis of long-term dialysis treatments. Hence, these parameters should also be considered goals to be achieved during WAK dialysis. Extracorporeal blood volume and ultrafiltration performance should be considered for the maintenance of euvolemia, particularly in hemodynamically unstable patients. Although water intake was considered, most of the important parameters listed earlier were not considered in this study. In particular, the application of a WAK system in clinical practice should consider not only a target uremic toxin concentration but also a personalized dialysis dose and schedule that is flexible according to the overall clinical requirements.
Another limitation of the present study is that the methods and results were based on the theoretical assumptions of a typical mathematical model. Various parameters related to the biology and pathological conditions of the patient, lifestyle changes, technical specifications, and the clinical environments should be considered in clinical practice for the use of continuous WAK treatment. Therefore, the methods and results provided in this study should be validated and adjusted based on future clinical trials with the WAK system.
In conclusion, the required dialysis clearance for an anuric patient model with a WAK system is primarily influenced by both the TAC target and the daily dialysis pause time when the patient's body weight and endogenous solute generation rate are accounted for. The numerical results indicated that the daily water intake volume does not affect the dose of the WAK treatment. Although numerous technical obstacles need to be overcome to enable the clinical application of WAK treatment, an affordable and reliable WAK system can eventually be developed via the performance of a series of in vitro and in vivo experiments followed by clinical trials. We expect that our results will contribute to the realization of the clinical application of WAKs by providing guidelines for both researchers and developers who seek to improve WAK systems by determining the dialysis clearances of dialyzers, blood flow rates, dialysis times with WAKs, etc. A practical approach for the implementation of a WAK would afford not only an improved dialysis efficacy but also an improvement in the quality of life of the patients with ESRD.
